(Q48598865)

13 February 2018

title

Effects of beta-IFN-1b treatment in MS patients on adhesion between PBMNCs, HUVECs and MS-HBECs: an in vivo and in vitro study. (English)

1 reference

13 February 2018

author name string

Corsini E

1

1 reference

13 February 2018

Gelati M

2

1 reference

13 February 2018

Dufour A

3

1 reference

13 February 2018

Massa G

4

1 reference

13 February 2018

Nespolo A

5

1 reference

13 February 2018

Ciusani E

6

1 reference

13 February 2018

Milanese C

7

1 reference

13 February 2018

La Mantia L

8

1 reference

13 February 2018

Salmaggi A

9

1 reference

13 February 2018

publication date

1 October 1997

1 reference

13 February 2018

Journal of Neuroimmunology

published in

1 reference

13 February 2018

volume

79

1 reference

13 February 2018

page(s)

76-83

1 reference

13 February 2018

issue

1

1 reference

13 February 2018

Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

Interferon-beta impairs induction of HLA-DR antigen expression in cultured adult human astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

Adhesion of subsets of human blood mononuclear cells to endothelial cells in vitro, as quantified by flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

The effect of interferon beta-1b on lymphocyte-endothelial cell adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

Circulating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

Serum and cerebrospinal fluid levels of soluble adhesion molecules in multiple sclerosis: predominant intrathecal release of vascular cell adhesion molecule-1

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

Soluble Forms of Vascular Adhesion Molecules, E‐Selectin, ICAM‐1, and VCAM‐1: Pathological Significance

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

Circulating adhesion molecules in disease

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

beta-Interferon regulates the immunomodulatory activity of neonatal rodent microglia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

Soluble ICAM-1 serum levels in multiple sclerosis and viral encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

Interferon-beta downregulates interferon-gamma-induced class II MHC molecule expression and morphological changes in primary cultures of human brain microvessel endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

Contrasting effect of alpha/beta- and gamma-interferons on expression of macrophage Ia antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

Virus interference. I. The interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

Interferon beta-1b reduces interferon gamma-induced antigen-presenting capacity of human glial and B cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

Immunoregulatory effects of interferon-beta and interacting cytokines on human vascular endothelial cells. Implications for multiple sclerosis autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

Isolation of brain capillaries: a simplified technique

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

Treatment of multiple sclerosis with gamma interferon: exacerbations associated with activation of the immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

Interferon effects on interleukin-10 secretion. Mononuclear cell response to interleukin-10 is normal in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

Adhesion molecules on endothelial cells in the central nervous system: an emerging area in the neuroimmunology of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

Interleukin-10 prevents experimental allergic encephalomyelitis in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

Circulating ICAM-1 isoforms: diagnostic prospects for inflammatory and immune disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood-brain barrier damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

Interferon-beta downregulates expression of VLA-4 antigen and antagonizes interferon-gamma-induced expression of HLA-DQ on human peripheral blood monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

Interferon beta-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2897%2900114-8

7 January 2021

10.1016/S0165-5728(97)00114-8

Identifiers

DOI

1 reference

13 February 2018

PubMed ID

9357450

1 reference

13 February 2018